Association Between Achieved Low-Density Lipoprotein Levels and Major Adverse Cardiac Events in Patients With Stable Ischemic Heart Disease Taking Statin Treatment.

In simple terms

This study is like noticing that people who wear red shirts tend to be taller - it shows a pattern but doesn't prove the shirts make them taller. It can tell us things are connected, but not why.

33%

Analysis score

33/ 72

Maximum 72 for a cohort study.

Where the score came from

Reporting0

Methodology38

Publication100

Statistical0

Study type (basis of the score)

Cohort Study

Level 2b - Individual cohort study

What’s the bottom line?

Researchers looked at heart patients taking cholesterol medicine to see if lower cholesterol numbers meant fewer heart problems.

Where does this study sit?

Reviews of RCTs (Meta-analyses)

Max 100

Randomized Trials

Max 90

Reviews of Cohort Studies

Max 85

Cohort Studies

Max 72

Reviews of Case-Control Studies

Max 63

Case-Control Studies

Max 58

Cross-Sectional & Case Series

Max 50

Expert Opinion

Max 5

StrongerWeaker

Cohort Studies

Level 2b

33 / 100

Quality score

Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.

Cannot establish causation

Save studies & get personalized insights

Create a free account to save this study, track new evidence as it comes in, and get breakdowns of studies in the topics you care about.

Key takeaways

Summary

Based on the study abstract and findings.

1This suggests getting cholesterol to 70-100 might be better than higher levels, but going under 70 doesn't seem to help more.
2Patients with cholesterol between 70-100 had 11% fewer heart problems than those with 100-130.
3Patients with cholesterol under 70 had about the same heart problems as those with 70-100.

Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data